Back
CapStar Financial Holdings Vs. Akero Therapeutics Industry Stock Comparison
Sell
13
CSTR
CapStar Financial Holdings
Last Price:
12.67
Seasonality Move:
-6.56%
Buy
59
AKRO
Akero Therapeutics
Last Price:
52.01
Seasonality Move:
18.98%
Sell
13
CapStar Financial Holdings (CSTR)
is a Sell
Is CapStar Financial Holdings a Buy, Sell or Hold?
- The current CapStar Financial Holdings [CSTR] share price is $12.81. The Score for CSTR is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
- CSTR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
59
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $46.73. The Score for AKRO is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CSTR Stock Price Chart
What is CapStar Financial Holdings's stock price today?
-
The CapStar Financial Holdings share price today is $12.81
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CSTR is experiencing buying pressure, which is a positive indicator for future bullish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $46.73
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
CSTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 48.68 | Sell |
| Chaikin Money Flow: | 73946 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.04 - 13.1) | Buy |
| Bollinger Bands (100): | (13.14 - 17.22) | Sell |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.39 | Buy |
| Relative Strength Index (14 RSI): | 58.79 | Buy |
| Chaikin Money Flow: | 386526 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.21 - 46.79) | Buy |
| Bollinger Bands (100): | (40.39 - 47.63) | Buy |
CSTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.74 | Buy |
| 20-day SMA: | 12.58 | Buy |
| 50-day SMA: | 13.48 | Sell |
| 200-day SMA: | 16.85 | Sell |
| 8-day EMA: | 12.63 | Buy |
| 20-day EMA: | 12.77 | Buy |
| 50-day EMA: | 13.52 | Sell |
| 200-day EMA: | 16.26 | Sell |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.66 | Buy |
| 20-day SMA: | 45.7 | Buy |
| 50-day SMA: | 42.72 | Buy |
| 200-day SMA: | 39.68 | Buy |
| 8-day EMA: | 45.2 | Buy |
| 20-day EMA: | 45.01 | Buy |
| 50-day EMA: | 44.08 | Buy |
| 200-day EMA: | 38.61 | Buy |
CapStar Financial Holdings Earnings Growth & CSTR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.43 per share, and an increase next year of $0.11 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.76 per share.
CapStar Financial Holdings Technical Analysis
| May-19 | May-22 | May-23 | May-24 | May-25 | May-26 | May-30 | May-31 | Jun-1 | Jun-2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics Technical Analysis
| May-19 | May-22 | May-23 | May-24 | May-25 | May-26 | May-30 | May-31 | Jun-1 | Jun-2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||